Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

I. Oblak · SciRah

Researcher profile · Semantic Scholar

I. Oblak

Share profile

I. Oblak — researcher profile on SciRah

h-index: 19
Works: 69
Citations: 898

Most-cited papers

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study
V. Velenik, J. Ocvirk, M. Mušič, M. Bračko +6 more
2011Radiation Oncology97 citations Open access
Semantic Scholar
Impact of COVID-19 on Cancer Diagnosis and Management in Slovenia – Preliminary Results
V. Zadnik, Ana Mihor, S. Tomšič, T. Žagar +3 more
2020Radiology and Oncology66 citations Open access
Semantic Scholar
Postoperative concomitant irradiation and chemotherapy with mitomycin C and bleomycin for advanced head-and-neck carcinoma.
L. Šmid, M. Budihna, B. Zakotnik, E. Šoba +6 more
2003International Journal of Radiation Oncology, Biology, Physics62 citations
Semantic Scholar
A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer.
V. Velenik, J. Ocvirk, I. Oblak, F. Anderluh
2010European Journal of Surgical Oncology60 citations
Semantic Scholar
Breast Size Impact on Adjuvant Radiotherapy Adverse Effects and Dose Parameters in Treatment Planning
I. Ratoša, A. Jenko, I. Oblak
2018Radiology and Oncology46 citations Open access
Semantic Scholar
Oral glutamine supplementation during preoperative radiochemotherapy in patients with rectal cancer: a randomised double blinded, placebo controlled pilot study.
Nada Rotovnik Kozjek, L. Kompan, P. Soeters, I. Oblak +5 more
2011Clinical Nutrition45 citations
Semantic Scholar
Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trial.
V. Velenik, F. Anderluh, I. Oblak, P. Strojan +1 more
2006Croatian Medical Journal37 citations
Semantic Scholar
Acute Toxicity and Tumor Response in Locally Advanced Rectal Cancer After Preoperative Chemoradiation Therapy With Shortening of the Overall Treatment Time Using Intensity-Modulated Radiation Therapy With Simultaneous Integrated Boost: A Phase 2 Trial.
J. But-Hadžić, F. Anderluh, E. Brecelj, I. Edhemovic +9 more
2016International Journal of Radiation Oncology, Biology, Physics32 citations
Semantic Scholar
Validation of a survival score for patients treated with whole-brain radiotherapy for brain metastases
Liesa Dziggel, B. Segedin, N. H. Podvrsnik, I. Oblak +2 more
2013Strahlentherapie und Onkologie (Print)32 citations
Semantic Scholar
Patterns of failure in patients with locally advanced head and neck cancer treated postoperatively with irradiation or concomitant irradiation with Mitomycin C and Bleomycin.
B. Zakotnik, M. Budihna, L. Šmid, E. Šoba +5 more
2007International Journal of Radiation Oncology, Biology, Physics32 citations
Semantic Scholar
Long term outcome after combined modality treatment for anal cancer
I. Oblak, P. Petric, F. Anderluh, V. Velenik +1 more
2012Radiology and Oncology31 citations Open access
Semantic Scholar
Telemedicine in Radiation Oncology Post–COVID-19 Pandemic: There Is No Turning Back
M. Oražem, I. Oblak, Tanja Spanic, I. Ratoša
2020International Journal of Radiation Oncology, Biology, Physics27 citations Open access
Semantic Scholar
A new survival score for patients with brain metastases from non-small cell lung cancer
D. Rades, Liesa Dziggel, B. Segedin, I. Oblak +5 more
2013Strahlentherapie und Onkologie (Print)26 citations
Semantic Scholar
Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer
V. Velenik, I. Oblak, F. Anderluh
2010Radiation Oncology26 citations Open access
Semantic Scholar
The first survival score for patients with brain metastases from small cell lung cancer (SCLC).
D. Rades, L. Dziggel, B. Segedin, I. Oblak +3 more
2013Clinical neurology and neurosurgery (Dutch-Flemish ed. Print)23 citations
Semantic Scholar
Induction Chemotherapy, Chemoradiotherapy and Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer - Long-term Results of Phase II OIGIT-01 Trial
D. Golo, J. But-Hadžić, F. Anderluh, E. Brecelj +6 more
2018Radiology and Oncology21 citations Open access
Semantic Scholar
A survival score for patients with brain metastases from less radiosensitive tumors treated with whole-brain radiotherapy alone
Liesa Dziggel, B. Segedin, N. H. Podvrsnik, I. Oblak +2 more
2013Strahlentherapie und Onkologie (Print)21 citations
Semantic Scholar
A simple survival score for patients with brain metastases from breast cancer
D. Rades, Liesa Dziggel, B. Segedin, I. Oblak +5 more
2013Strahlentherapie und Onkologie (Print)20 citations
Semantic Scholar
The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin
I. Oblak, Monika Češnjevar, M. Anzic, J. Hadžić +5 more
2016Radiology and Oncology19 citations Open access
Semantic Scholar
Cetuximab in preoperative treatment of rectal cancer – term outcome of the XERT trial
V. Velenik, J. Ocvirk, I. Oblak, F. Anderluh
2012Radiology and Oncology19 citations Open access
Semantic Scholar
Treatment-related Cardiovascular Toxicity in Long-term Survivors of Testicular Cancer
J. Gugić, L. Zaletel, I. Oblak
2016Radiology and Oncology16 citations Open access
Semantic Scholar
Total Neoadjuvant Treatment of Locally Advanced Rectal Cancer with High Risk Factors in Slovenia
Mojca Tuta, N. Boc, E. Brecelj, M. Omejc +6 more
2019Radiology and Oncology13 citations Open access
Semantic Scholar
Quality of life in patients after combined modality treatment of rectal cancer: Report of a prospective phase II study
V. Velenik, I. Oblak, F. Anderluh
200812 citations Open access
Semantic Scholar
Radiotherapy for Perianal Paget's Disease: A Case Report
V. Velenik, B. Segedin, F. Anderluh, I. Oblak +1 more
2008Tumori11 citations
Semantic Scholar
Results of adjuvant radiochemotherapy for gastric adenocarcinoma in Slovenia.
I. Oblak, V. Velenik, F. Anderluh, Primo? Strojan
2007European Journal of Surgical Oncology11 citations
Semantic Scholar
Hemoglobin as a factor influencing the outcome in inoperable oropharyngeal carcinoma treated by concomitant radiochemotherapy.
I. Oblak, P. Strojan, Branko Zakotnik, Marjan Budihna +1 more
2003Neoplasma (Bratislava)11 citations
Semantic Scholar
The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancer
I. Oblak, V. Velenik, F. Anderluh, B. Možina +1 more
2013Radiology and Oncology10 citations Open access
Semantic Scholar
Breast Size and Dose to Cardiac Substructures in Adjuvant Three-dimensional Conformal Radiotherapy Compared to Tangential Intensity Modulated Radiotherapy
I. Ratoša, A. Jenko, Z. Sljivic, M. Pirnat +1 more
2020Radiology and Oncology8 citations Open access
Semantic Scholar
Anal cancer chemoirradiation with curative intent - a single institution experience.
I. Oblak, P. Petric, F. Anderluh, V. Velenik +2 more
2009Neoplasma (Bratislava)8 citations Open access
Semantic Scholar
Neoadjuvant cetuximab, capecitabine, and radiotherapy (RT) in locally advanced resectable rectal cancer: results of a phase II trial.
V. Velenik, Janja Ocvirk, I. Oblak, F. Anderluh
2016Journal of Clinical Oncology7 citations
Semantic Scholar
Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma
I. Oblak, M. Vidmar, F. Anderluh, V. Velenik +2 more
2014Radiology and Oncology6 citations Open access
Semantic Scholar
Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or III
I. Oblak, F. Anderluh, V. Velenik, B. Možina +3 more
2011Radiology and Oncology6 citations Open access
Semantic Scholar
Impact of the COVID-19 Epidemic on Cancer Burden and Cancer Care in Slovenia: A Follow-up Study
T. Žagar, S. Tomšič, V. Zadnik, N. Bric +5 more
2022Radiology and Oncology5 citations Open access
Semantic Scholar
Postoperative radiochemotherapy for gastric adenocarcinoma: long term results
I. Oblak, F. Anderluh, V. Velenik
20095 citations Open access
Semantic Scholar
Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancer
I. Ratoša, I. Oblak, F. Anderluh, V. Velenik +3 more
2015Radiology and Oncology4 citations Open access
Semantic Scholar
Definitive Radiochemotherapy in Esophageal Cancer - A Single Institution Experience
F. Anderluh, Miha Toplak, V. Velenik, I. Oblak +4 more
2019Radiology and Oncology3 citations Open access
Semantic Scholar
Long term efficacy results from the phase II CRAB trial: Neoadjuvant bevacizumab, capecitabine and radiotherapy in locally advanced rectal cancer.
V. Velenik, Mirko Omejc, Janja Ocvirk, I. Edhemovic +3 more
2018Annals of Oncology3 citations Open access
Semantic Scholar
Results of postoperative radiochemotherapy of the patients with resectable gastroesophageal junction adenocarcinoma in Slovenia
Ana Jeromen, I. Oblak, F. Anderluh, V. Velenik +2 more
2012Radiology and Oncology3 citations Open access
Semantic Scholar
Neoadjuvant bevacizumab, capecitabine, and radiotherapy in locally advanced rectal cancer: Interim results of a phase II CRAB trial.
V. Velenik, J. Ocvirk, M. Omejc, M. Mušič +5 more
20103 citations
Semantic Scholar
The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin.
I. Oblak, Monika Češnjevar, M. Anzic, J. Hadžić +5 more
2016Radiology and Oncology2 citations Open access
Semantic Scholar
Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment
A. Perpar, E. Brecelj, N. Kozjek, F. Anderluh +3 more
2015Radiology and Oncology2 citations Open access
Semantic Scholar
P-0018CAPECITABINE IN POSTOPERATIVE RADIOCHEMOTHERAPY FOR GASTRIC ADENOCARCINOMA
I. Oblak, M. Vidmar, F. Anderluh, V. Velenik +1 more
20132 citations Open access
Semantic Scholar
Managing anemia with epoetin alfa in patients with rectal cancer
V. Velenik, I. Oblak, Veronika Kodre
20052 citations
Semantic Scholar
P-293 A single institution experience of SBRT treatment for liver metastases and primary liver tumours
I. Oblak, A. Secerov-Ermenc, D. Grabec, N. Boc +4 more
2023Annals of Oncology1 citations Open access
Semantic Scholar
Total neoadjuvant treatment of "ugly" rectal cancers in Slovenia.
V. Velenik, N. Boc, J. Ocvirk, E. Brecelj +6 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
The Impact of the Radiation Dose Delivered to the Fundus and the Stomach on the Incidence of Anastomotic Complications for Patients with Gastro-Esophageal Junction Cancer Treated with Neoadjuvant Chemoradiotherapy and Surgery
A. Ermenc, J. Hadžić, A. J. Peressutti, F. Anderluh +3 more
2019International Journal of Radiation Oncology, Biology, Physics1 citations Open access
Semantic Scholar
Breast size impact on clinical adverse effects and radiotherapy treatment planning parameters
I. Ratoša, A. Jenko, I. Oblak
20181 citations
Semantic Scholar
Pomen hipoksije pri obsevanju
P. Korošec, M. Anzic, Monika Češnjevar, G. Plavc +1 more
20151 citations
Semantic Scholar
6019 Phase II XERT trial: Neoadjuvant cetuximab, capecitabine and radiotherapy (RT) in locally advanced resectable rectal cancer
V. Velenik, J. Ocvirk, I. Oblak, F. Anderluh
20091 citations
Semantic Scholar
Total Neoadjuvant Therapy Outcomes and Watch-and-Wait Feasibility in Locally Advanced Rectal Cancer: A Single-Institution Retrospective Cohort Study
Manuel Ramanović, F. Anderluh, A. J. Peressutti, P. Korošec +3 more
2026Cancers0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

V. Velenik×33
Invite
V. Velenik — researcher profile on SciRah
F. Anderluh×32
Invite
F. Anderluh — researcher profile on SciRah
Ana Jeromen×9
Invite
Ana Jeromen — researcher profile on SciRah
J. Ocvirk×8
Invite
J. Ocvirk — researcher profile on SciRah

×6

Invite

E. Brecelj — researcher profile on SciRah

Invite

I. Ratoša — researcher profile on SciRah

J. But-Hadžić×6

Invite

J. But-Hadžić — researcher profile on SciRah

Invite

B. Segedin — researcher profile on SciRah

Invite

A. Ermenc — researcher profile on SciRah

I. Edhemovic×5

Invite

I. Edhemovic — researcher profile on SciRah

Invite

P. Strojan — researcher profile on SciRah

A. Secerov-Ermenc×5

Invite

A. Secerov-Ermenc — researcher profile on SciRah